Carregant...

NLRP3 Inflammasome Is a Target for Development of Broad-Spectrum Anti-Infective Drugs

We describe the molecular mode of action and pharmacodynamics of a new molecular entity (NME) that induces the NLRP3 inflammasome-mediated innate immune response. This innate response reduces the pathogen load in an experimentally induced methicillin-resistant Staphylococcos aureus infection, enhanc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thacker, James D., Balin, Brian J., Appelt, Denah M., Sassi-Gaha, Sihem, Purohit, Mitali, Rest, Richard F., Artlett, Carol M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318317/
https://ncbi.nlm.nih.gov/pubmed/22290938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06372-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!